Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Co­ag­u­la­tion In­hibitors

Coagulation inhibitors (also called anti-coagulants) are proteins which counteract the blood coagulation process.

Name Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date Further Information

An­binex

Gri­fols Deutsch­land GmbH

7812.00.00 03.07.1986

AT III NF 500

Take­da GmbH

7208.02.00 18.09.1986

AT III NF 1000

Take­da GmbH

7208.03.00 18.09.1986

ATe­na­tiv

OC­TAPHAR­MA GmbH

4310.00.00 14.05.1984

Berinert 500

Haema­to Pharm GmbH

PEI.H.12103.01.1 27.04.2021

Berinert 500

CC-Phar­ma GmbH

PEI.H.12113.01.1 19.05.2021

Berinert 500

Ori­farm GmbH

PEI.H.12110.02.1 25.05.2021

Berinert 500

CSL Behring GmbH

294.00.00 23.07.1984

Berinert 1500

Ori­farm GmbH

PEI.H.12110.01.1 25.05.2021

Berinert 1500

CLS Behring GmbH

294.01.00 10.02.2015

Berinert 2000

CLS Behring GmbH

294.02.00 29.01.2018

Berinert 3000

CLS Behring GmbH

294.03.00 29.01.2018

CE­PROTIN

Take­da Man­u­fac­tur­ing Aus­tria AG (TMAG)

EU/1/01/190 16.07.2001

EPAR Ce­protin

Cin­ryze

Take­da Man­u­fac­tur­ing Aus­tria AG

EU/1/11/688 15.06.2011

EPAR: Cin­ryze

Ky­bernin P 500

CSL Behring GmbH

13101.00.00 07.03.1988

Ky­bernin P 1000

CSL Behring GmbH

13101.01.00 07.03.1988

Ru­con­est

Pharm­ing Group N.V., 2333 CR Lei­den, Nieder­lande

EU/1/10/641 28.10.2010

EPAR: Ru­con­est

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 514 in BAnz AT 01.03.2024 B8.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 04.03.2024